This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Prostate Cancer
and you are a man who is
over 18
years old
Phase
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

French epidemiological data have shown a heterogeneous distribution of the risk of mortality from prostate cancer according to region. The main objective is to describe the distribution of prostate cancer stages when first line hormonal therapy is introduced (overall and by region).

Provided treatments

  • Drug: Degarelix or GnRH agonist
Tris trial is registered with FDA with number: NCT01729676. The sponsor of the trial is Ferring Pharmaceuticals and it is looking for 315 volunteers for the current phase.
Official trial title:
Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation: FACT STUDY